Fig. 4From: Increased serum IL-2, IL-4, IL-5 and IL-12p70 levels in AChR subtype generalized myasthenia gravisSerum IL-2 (A), IL-4 (B), IL-5 (C) and IL-12p70 (D) levels in subgroups stratified by disease duration (duration ≤ 6 months versus duration > 6 months). *P < 0.05Back to article page